查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1463146

流感治療藥物市場、佔有率、規模、趨勢、產業分析報告：依流感類型、治療、分銷管道、地區、細分市場、預測，2024-2032年

Influenza Medications Market Share, Size, Trends, Industry Analysis Report, By Influenza Type (Influenza A and Influenza B); By Treatment; By Distribution Channel; By Region; Segment Forecast, 2024- 2032
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，預計到2032年，全球流感藥物市場規模將達到13.8621億美元。 該報告提供了對當前市場動態的詳細見解，並對未來市場成長進行了分析。

季節性流感流行、傳染性呼吸道疾病的流行以及發生流感相關併發症的高風險患者數量的增加是推動市場成長的主要因素。 政府不斷採取的舉措，例如控制流感傳播的疫苗接種計劃以及對流感早期診斷和治療重要性的認識，預計也將進一步推動市場成長。

例如，衛生防護中心2023年9月報告指出，政府疫苗接種計畫將於2023年10月開始，政府將繼續提供免費季節性流感疫苗接種。

此外，我們正在努力加強流感治療藥物領域的研發活動，針對病毒的不同階段開發出更有效的抗病毒藥物，能夠更有效地治療流感。藥物的發展。 例如，根據牛津大學 2023 年 10 月發佈的報告，RECOVERY 試驗已擴大到研究流感的治療方法，流感每年導致約 29 萬至 65 萬人死亡。

由於需要更有效、更安全的抗病毒藥物來對抗流感的傳播，公司正在推出創新的抗病毒藥物，例如下一代抗病毒藥物。 這種抗病毒藥物具有更高的功效、針對多種流感病毒株的更廣譜活性以及更少的副作用，對流感治療的需求產生了積極影響。

此外，個人化醫療的進步，即根據患者個體特徵（例如免疫反應和遺傳易感性）量身定制流感治療，正在進一步增加全球產品需求。 例如，印度科學研究所於 2023 年 7 月進行的一項研究發現，□啶甲酸可以阻止導致包括流感在內的多種疾病的病毒，並且據報導還可能有助於對抗某些病毒性疾病。

流感治療藥物市場報告亮點

由於發病率上升以及人們對正確劑量重要性的認識，甲型流感治療領域佔據了重要佔有率

磷酸奧司他韋憑藉高效、抗多種菌株等優勢佔據大部分市場佔有率

線上藥局的興起為患者帶來了多種好處，包括便利性和可近性。

由於流感流行和增加研發投資以開發新配方，北美在市場上佔據主導地位。

目錄

第一章簡介

第 2 章執行摘要

第三章研究方法

第四章全球流感藥市場洞察

  • 流感治療市場－通路概況
  • 流感治療藥物市場動態
    • 推動者和機會
      • 流感發生率不斷上升，公共衛生意識不斷提高
      • 加強研發力道並收緊監管
    • 抑制因素和課題
      • 季節性需求和替代療法的可用性
  • PESTEL 分析
  • 流感治療藥物市場通路趨勢
  • 價值鏈分析
  • 新冠肺炎 (COVID-19) 影響分析

第五章以流感類型劃分的全球市場

  • 主要發現
  • 簡介
  • 甲型流感
  • B型流感

第 6 章依處理方式劃分的全球市場

  • 主要發現
  • 簡介
  • 巴洛沙韋酯
  • 磷酸奧司他韋
  • 其他

第 7 章依通路劃分的世界市場

  • 主要發現
  • 簡介
  • 醫院藥房
  • 零售藥局
  • 網路藥局
  • 其他

第 8 章依地區劃分的世界市場

  • 主要發現
  • 簡介
    • 2019-2032 年流感治療市場評估（依地區）
  • 流感藥物市場 - 北美
    • 北美：2019-2032 年流感治療市場（以流感類型）
    • 北美：流感治療藥物市場（依通路），2019-2032 年
    • 北美：流感藥物市場，依治療方法，2019-2032 年
    • 流感治療藥物市場 - 美國
    • 流感藥物市場 - 加拿大
  • 流感藥物市場 - 歐洲
    • 歐洲：2019-2032 年流感治療市場（以流感類型）
    • 歐洲：流感治療市場（依通路），2019-2032 年
    • 歐洲：流感治療市場（依治療方式），2019-2032 年
    • 流感藥物市場 - 英國
    • 流感藥物市場 - 法國
    • 流感藥物市場 - 德國
    • 流感藥物市場 - 義大利
    • 流感藥物市場 - 西班牙
    • 流感藥物市場 - 荷蘭
    • 流感藥物市場 - 俄羅斯
  • 流感治療市場 - 亞太地區
    • 亞太地區：2019-2032 年流感藥物市場（依流感類型）
    • 亞太地區：流感治療藥物市場（依通路），2019-2032 年
    • 亞太地區：流感藥物市場（依治療方法），2019-2032 年
    • 流感治療藥物市場 - 中國
    • 流感藥物市場 - 印度
    • 流感藥物市場 - 馬來西亞
    • 流感治療藥物市場 - 日本
    • 流感治療藥物市場 - 印尼
    • 流感治療藥物市場 - 韓國
  • 流感藥物市場 - 中東和非洲
    • 中東和非洲：2019-2032 年流感藥物市場（依流感類型）
    • 中東和非洲：流感治療藥物市場（依分銷管道），2019-2032 年
    • 中東與非洲：2019-2032 年流感藥物市場（依治療方式）
    • 流感藥物市場 - 沙烏地阿拉伯
    • 流感治療藥物市場 - 阿聯酋
    • 流感藥物市場 - 以色列
    • 流感藥物市場 - 南非
  • 流感藥物市場 - 拉丁美洲
    • 拉丁美洲：2019-2032 年流感藥物市場（以流感類型）
    • 拉丁美洲：流感治療藥物市場，依通路劃分，2019-2032 年
    • 拉丁美洲：流感藥物市場，依治療方法，2019-2032 年
    • 流感藥物市場 - 墨西哥
    • 流感藥物市場 - 巴西
    • 流感藥物市場 - 阿根廷

第九章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 合作/協作/合約/出版物

第十章公司簡介

  • AbbVie（US）
  • AstraZeneca（UK）
  • Bayer AG（Germany）
  • Bharat Biotech（India）
  • BioCryst Pharmaceuticals（US）
  • Daiichi Sankyo（Japan）
  • Mylan（US）
  • Novartis AG（Switzerland）
  • Roche Diagnostics（Switzerland）
  • Sanofi SA（France）
  • Seqirus（Australia）
Product Code: PM4800

The global influenza medications market size is expected to reach USD 1,386.21 million by 2032, according to a new study by Polaris Market Research. The report "Influenza Medications Market Share, Size, Trends, Industry Analysis Report, By Influenza Type (Influenza A and Influenza B); By Treatment; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The proliferation of seasonal flu, greater prevalence of contagious respiratory illness, and increasing patient population who are at higher risk of developing flu-related complications, are key factors driving the market growth. Growing number of government initiatives like vaccination programs for controlling the spread of influenza and awareness regarding the importance of early diagnosis and treatment of influenza, are further anticipated to propel market growth.

For instance, according a report by the Centre for Health Protection in September 2023, the Government Vaccination Programme was launched in October 2023 under which the government continued to provide seasonal influenza vaccination for free of cost.

Furthermore, growing research & development activities in the field of influenza medications and growing number of pharmaceutical companies implementing on the development of more effective antiviral drugs that can treat influenza more efficiently through targeting different stages of viral, are further boosting the market's growth. For instance, according to a report by the University of Oxford in October 2023, the RECOVERY trail has been expanded for investigating treatments for influenza that cause deaths of approx. 290,000 to 650,000 people each year.

As the need for effective and safer antiviral drugs to combat the spread of influenza, companies are introducing innovative antiviral drugs like next-generation antiviral drugs which offer enhanced efficacy, broader spectrum of activity against the several influenza strains, and reduced side effects, which is impacting the demand for influenza medications in a positive way.

Additionally, ongoing advances in personalized medicine tailoring to influenza treatment based on individual patient characteristics like immune response and genetic make-up, further escalating the product demand globally. For instance, according to a study done by the Indian Institute of Science in July 2023, it is reported that picolinic acid has the potential to block various disease-causing viruses including influenza and it also help to fight against several viral diseases.

Influenza Medications Market Report Highlights

Influenza A segment accounted for notable share, owing to rising incidences and awareness regarding the importance of proper medications

Oseltamivir phosphate segment held the majority share, that is attributed to its advantages including higher efficiency and effectiveness against several strains

Online pharmacies segment will grow at highest pace, emergence of online pharmacy platforms offering several benefits to patients like convenience and easy accessibility

North America dominated the market, on account of prevalence of influenza and rising investments in R&D activities to develop new formulations

The key market players include Bayer, Roche Diagnostics, Novartis, Sanofi, AstraZeneca, AbbVie, BioCryst Pharmaceuticals, and Mylan

Polaris Market Research has segmented the influenza medications market report based on influenza type, treatment, distribution channel, and region:

Influenza Medications, Influenza Type Outlook (Revenue - USD Million, 2023 - 2032)

  • Influenza A
  • Influenza B

Influenza Medications, Treatment Outlook (Revenue - USD Million, 2023 - 2032)

  • Baloxavir Marboxil
  • Oseltamivir Phosphate
  • Others

Influenza Medications, Distribution Channel Outlook (Revenue - USD Million, 2023 - 2032)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Influenza Medications, Regional Outlook (Revenue - USD Million, 2023 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Influenza Medications Market Insights

  • 4.1. Influenza Medications Market - Distribution Channel Snapshot
  • 4.2. Influenza Medications Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising incidences of influenza and increasing awareness about public health
      • 4.2.1.2. Increased R&D efforts and growing regulatory
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Seasonal demand and availability of alternative treatments
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Influenza Medications Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Influenza Medications Market, by Influenza Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • 5.3. Influenza A
    • 5.3.1. Global Influenza Medications Market, by Influenza A, by Region, 2019-2032 (USD Million)
  • 5.4. Influenza B
    • 5.4.1. Global Influenza Medications Market, by Influenza B, by Region, 2019-2032 (USD Million)

6. Global Influenza Medications Market, by Treatment

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • 6.3. Baloxavir Marboxil
    • 6.3.1. Global Influenza Medications Market, by Baloxavir Marboxil, by Region, 2019-2032 (USD Million)
  • 6.4. Oseltamivir Phosphate
    • 6.4.1. Global Influenza Medications Market, by Oseltamivir Phosphate, by Region, 2019-2032 (USD Million)
  • 6.5. Others
    • 6.5.1. Global Influenza Medications Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Influenza Medications Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • 7.3. Hospitals Pharmacies
    • 7.3.1. Global Influenza Medications Market, by Hospitals Pharmacies, By Region, 2019-2032 (USD Million)
  • 7.4. Retail Pharmacies
    • 7.4.1. Global Influenza Medications Market, by Retail Pharmacies, By Region, 2019-2032 (USD Million)
  • 7.5. Online Pharmacies
    • 7.5.1. Global Influenza Medications Market, by Online Pharmacies, By Region, 2019-2032 (USD Million)
  • 7.6. Others
    • 7.6.1. Global Influenza Medications Market, by Others, By Region, 2019-2032 (USD Million)

8. Global Influenza Medications Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Influenza Medications Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Influenza Medications Market - North America
    • 8.3.1. North America: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
    • 8.3.2. North America: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.3.3. North America: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.3.4. Influenza Medications Market - U.S.
      • 8.3.4.1. U.S.: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.3.5. Influenza Medications Market - Canada
      • 8.3.5.1. Canada: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • 8.4. Influenza Medications Market - Europe
    • 8.4.1. Europe: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.4.3. Europe: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.4. Influenza Medications Market - UK
      • 8.4.4.1. UK: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.5. Influenza Medications Market - France
      • 8.4.5.1. France: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.5.3. France: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.6. Influenza Medications Market - Germany
      • 8.4.6.1. Germany: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.7. Influenza Medications Market - Italy
      • 8.4.7.1. Italy: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.8. Influenza Medications Market - Spain
      • 8.4.8.1. Spain: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.9. Influenza Medications Market - Netherlands
      • 8.4.9.1. Netherlands: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.10. Influenza Medications Market - Russia
      • 8.4.10.1. Russia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • 8.5. Influenza Medications Market - Asia Pacific
    • 8.5.1. Asia Pacific: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.4. Influenza Medications Market - China
      • 8.5.4.1. China: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.4.3. China: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.5. Influenza Medications Market - India
      • 8.5.5.1. India: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.5.3. India: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.6. Influenza Medications Market - Malaysia
      • 8.5.6.1. Malaysia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.7. Influenza Medications Market - Japan
      • 8.5.7.1. Japan: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.8. Influenza Medications Market - Indonesia
      • 8.5.8.1. Indonesia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.9. Influenza Medications Market - South Korea
      • 8.5.9.1. South Korea: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • 8.6. Influenza Medications Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.6.4. Influenza Medications Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.6.5. Influenza Medications Market - UAE
      • 8.6.5.1. UAE: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.6.6. Influenza Medications Market - Israel
      • 8.6.6.1. Israel: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.6.7. Influenza Medications Market - South Africa
      • 8.6.7.1. South Africa: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • 8.7. Influenza Medications Market - Latin America
    • 8.7.1. Latin America: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.7.4. Influenza Medications Market - Mexico
      • 8.7.4.1. Mexico: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.7.5. Influenza Medications Market - Brazil
      • 8.7.5.1. Brazil: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.7.6. Influenza Medications Market - Argentina
      • 8.7.6.1. Argentina: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AbbVie (US)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. AstraZeneca (UK)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Bayer AG (Germany)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Bharat Biotech (India)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. BioCryst Pharmaceuticals (US)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Daiichi Sankyo (Japan)
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Mylan (US)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Novartis AG (Switzerland)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Roche Diagnostics (Switzerland)
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Sanofi SA (France)
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Seqirus (Australia)
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development

List of Tables

  • Table 1 Global Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 2 Global Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 3 Global Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 4 Influenza Medications Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 6 North America: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 7 North America: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 8 U.S.: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 9 U.S.: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 10 U.S.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 11 Canada: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 12 Canada: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 13 Canada: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 14 Europe: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 15 Europe: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 16 Europe: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 17 UK: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 18 UK: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 19 UK: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 20 France: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 21 France: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 22 France: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 23 Germany: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 24 Germany: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 25 Germany: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 26 Italy: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 27 Italy: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 28 Italy: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 29 Spain: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 30 Spain: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 31 Spain: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 32 Netherlands: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 33 Netherlands: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 34 Netherlands: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 35 Russia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 36 Russia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 37 Russia: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 41 China: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 42 China: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 43 China: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 44 India: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 45 India: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 46 India: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 47 Malaysia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 48 Malaysia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 49 Malaysia: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 50 Japan: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 51 Japan: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 52 Japan: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 53 Indonesia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 54 Indonesia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 55 Indonesia: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 56 South Korea: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 57 South Korea: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 58 South Korea: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 65 UAE: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 66 UAE: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 67 UAE: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 68 Israel: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 69 Israel: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 70 Israel: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 71 South Africa: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 72 South Africa: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 73 South Africa: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 74 Latin America: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 75 Latin America: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 76 Latin America: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 77 Mexico: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 78 Mexico: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 79 Mexico: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 80 Brazil: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 81 Brazil: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 82 Brazil: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 83 Argentina: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 84 Argentina: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 85 Argentina: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Influenza Medications Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Treatment
  • Figure 7. Global Influenza Medications Market, by Treatment, 2022 & 2032 (USD Million)
  • Figure 8. Market by Influenza Type
  • Figure 9. Global Influenza Medications Market, by Influenza Type, 2022 & 2032 (USD Million)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Influenza Medications Market, by Distribution Channel, 2022 & 2032 (USD Million)
  • Figure 12. Influenza Medications Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Influenza Medications Market